Driving Pathology Forward: Instem Strengthens Provantis ® with Continued Investment and Innovation
Deep Digital Integration
Provantis Pathology now offers enhanced support for digital pathology, allowing users to move effortlessly between Provantis data entry and external applications or data sources. A key highlight is the new, seamless integration with PathcoreFlow™, the powerful digital slide management system from Instem's strategic partner, Pathcore ®.
This integration bridges study management and high-resolution digital slide review, resulting in a more connected, consistent, and efficient pathology workflow. The connection - and its time-saving benefits - is now available for pathologists to implement in their research.
'Digital pathology is no longer a niche - it's a vital foundation for faster, more reliable preclinical insights,' said Charuta Bapat, Director of Product - Study Management at Instem. 'With the latest updates to our Provantis Pathology module and the upcoming release of Provantis 12, we're delivering the most advanced tools designed to help pathologists work more efficiently and with greater confidence.'
'We're incredibly proud of what this integration represents - a fully connected, digitally forward workflow for today's pathology professionals,' said Carlos Frade, Senior Director of Product Knowledge and Business Development at Instem. 'This is a huge step forward for our study management solutions, and we're excited to meet with Pathologists at STP to showcase everything Provantis can do.'
Instem's commitment to a more flexible, future-ready environment is further reinforced by Provantis' growing suite of APIs connecting to 19 different data domains. This includes enhanced Pathology APIs for smoother integration with digital platforms, along with Preclinical Libraries and Studies APIs to extend data interoperability.
Looking ahead in 2025, the upcoming Provantis 12 release will lay the groundwork for a new, non-GLP pathology solution. This module will enable more pathologists to integrate with the Provantis ecosystem - supporting protocol definition, necropsy, and reporting - and empowering pathology teams to work smarter and faster with minimal disruption.
Live Demonstrations at STP 2025
Instem's pathology team will be demonstrating these new features live at the STP Annual Symposium in Chicago, exploring:
New editing capabilities in the histopathology matrix, as part of the upcoming non-GLP pathology module.
A new integration in this module with smart glossaries for simplified terminology management.
How to get started with the Provantis and PathcoreFlow™ integration
These advancements are part of Instem's broader roadmap focused on efficiency, scalability, and comprehensive study support for your lab team.
For details on how Provantis is transforming digital pathology visit www.instem.com/study-management-spotlight-provantis-pathology. To schedule a live demo during or after the STP conference in Chicago, contact info@instem.com.
About Instem
Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Founded in the United Kingdom in 1969, Instem has deep roots internationally across North America, EMEA, and APAC. Instem maintains a commercial and technical presence throughout these regions and prides itself on localized support for its diverse client base.
About Pathcore
Pathcore ® is dedicated to advancing digital pathology through innovative software solutions that empower organizations with the tools they need to implement digital transformations. For over two decades, our co-founders have led and developed widely used platforms including PathcoreFlow™, the Sedeen Viewer™, and PathcoreScholar™.
Our applications support a wide range of clients in more than 68 countries and 2000 organizations, making data easily accessible and driving the adoption of digital pathology.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Freedom Holding Corp. Reports First Quarter Fiscal Year 2026 Financial Results
NEW YORK--(BUSINESS WIRE)--Freedom Holding Corp. (the 'Company') (NASDAQ: FRHC), a multinational diversified financial services holding company with a presence in 22 countries, today announced financial results for the first quarter of fiscal year 2026 ended June 30, 2025. Highlights during the quarter include the following: $533.4 million in total revenue, net, versus $455 million for the quarter ended June 30, 2024, a 17% increase Net income of $30.4 million, or $0.50 per diluted share, $0.51 per basic share Total assets of $9.7 billion Total customers across segments rose to 5.3 million at June 30, 2025 Added to the Russell 3000 ® Index on June 27, 2025 S&P Global Ratings revised its outlook to Positive from Stable and affirms Credit Ratings for Freedom KZ, Freedom EU, Freedom Global, and Freedom Bank KZ Fiscal First Quarter 2026 Financial Highlights: The Company recognized total revenue, net of $533.4 million in the fiscal 2026 first quarter, an increase of 17% from $455 million in the comparable prior-year period. Revenue rose at the brokerage, banking, and insurance segments. Insurance premiums earned, net of reinsurance rose by 18% to $153.3 million from last year's first quarter and the Company realized a net gain on trading securities of $45.6 million compared to a net loss of $52.1 million in last year's fiscal first quarter. The Company had a net gain on derivatives of $15.5 million in the fiscal 2026 first quarter, an increase of 24% from $12.5 million in last year's first quarter due to revaluation of currency swaps. The Company's total expense was approximately $492.9 million in fiscal 2026 first quarter as compared to $413.4 million in last year's first quarter. Net income was $30.4 million for the fiscal 2026 first quarter compared to $34.4 million in the first quarter of fiscal 2025. Basic and diluted earnings per share were $0.51 and $0.50, respectively, compared to $0.58 and $0.57 per share, respectively, in last year's first quarter. Weighted average common shares outstanding used to compute basic and diluted earnings per share for the quarter ended June 30, 2025 were 59.9 million and 61.1 million, respectively, and 59.3 million and 60.3 million, respectively, for the quarter ended June 30, 2024. Total assets were $9.7 billion on June 30, 2025, compared to $9.9 billion as of the fiscal 2025 year ended March 31, 2025. Continuing the Growth and Evolution of our Business Model 'Our results for the fiscal 2026 first quarter reflect the continuing growth and evolution of our business model,' said Timur Turlov, the Company's founder and chief executive officer. 'We have expanded our product portfolio, embraced the digital transformation of our platform, and strengthened our market presence. We are also elevating our profile in the investment community, as reflected by our inclusion in the Russell 3000® Index on June 27, 2025. We remain ever-grateful for the dedication and hard work of our 10,054 employees in 231 offices around the world.' Mr. Turlov noted the Company's success in transforming into a one-stop shop, multi-point financial ecosystem that allows clients to manage their diverse financial needs in partnership with a single, trusted provider. He continued, 'Our commitment to providing the highest level of client service and accountability, including the continuing success of our Super App, has allowed us to expand our client base to more than 5.3 million across our three primary segments, representing a nearly 5% increase from March 31, 2025. Our strong financial position will support our growth objectives for fiscal 2026, with a focus on continuing our investments in digital infrastructure and AI to build out the Freedom services portfolio.' Additional Fiscal First Quarter 2026 highlights Brokerage: Revenue increased to $176.3 million from $174.9 million, driven by increases in fee and commission income, net gain on trading securities, and interest income, partially offset by a decrease in net (loss)/gain on foreign exchange operations and lower other income. Total retail brokerage clients rose to 725,000 as of June 30, 2025 compared to 683,000 as of March 31, 2025. Brokerage services were offered at 44 offices as of June 30, 2025. Banking: Revenue increased by 60% to $146.2 million from $91.2 million, driven primarily by an increase of net gain in trading securities, partially offset by lower commission income, which was primarily driven by active use by customers of a cashback-based loyalty program. The loyalty program is leveraged to effectively reduce transaction costs for customers by supporting our customer base expansion and increasing engagement across the ecosystem. Total banking clients rose to 2,927,000 as of June 30, 2025, up from 2,515,000 as of March 31, 2025. Banking services were offered at 30 offices as of June 30, 2025. Insurance: Revenue rose by 18% to $174.0 million from $147.3 million, driven by improved insurance premiums earned, net of reinsurance from written insurance premiums due to the expansion of the Company's insurance operations such as pension annuity and accident insurance. Total insurance clients rose to 1,396,000 as of June 30, 2025, from 1,170,000 as of March 31, 2025. Insurance services were offered at 57 offices as of June 30, 2025. Other Segments: Revenue declined to $36.9 million from $41.6 million as additional lifestyle benefits were added for customers as we invest in and develop the telecom business as part our long-term strategic planning. Acquisition of Astel Group Ltd On April 30, 2025, the Company acquired 100% interest in Astel Group Ltd. Astel Group Ltd. is a provider of digital solutions and telecommunications services, and ranks among the largest telecom operators in Kazakhstan. Astel Group Ltd provides advanced IT solutions including information security and cloud services. The purpose of the acquisition of Astel Group Ltd was to use the acquired assets and licenses to develop our telecommunications business. As of April 30, 2025, the date of the acquisition of Astel Group Ltd, the fair value of net assets of Astel Group Ltd was $20.6 million. The total purchase price was $22.3 million. About Freedom Holding Corp. Freedom Holding Corp., a Nevada corporation, is a diversified financial services holding company conducting securities brokerage, investment research, investment counseling, securities dealing, commercial banking and insurance products through its subsidiaries, operating under the name Freedom Finance in Europe and Central Asia, and Freedom Capital Markets in the United States. Through its subsidiaries, Freedom Holding Corp. employs more than 10,054 people and is a professional participant in the Kazakhstan Stock Exchange, the Astana International Exchange, the Republican Stock Exchange of Tashkent, International Trading System Limited, Armenia Stock Exchange, Kyrgyz Stock Exchange, the Uzbek Republican Currency Exchange and is a member of the New York Stock Exchange and the Nasdaq Stock Exchange. Freedom Holding Corp.'s common shares are registered under the United States Securities Exchange Act of 1934 and are traded under the symbol FRHC on the Nasdaq Capital Market, operated by Nasdaq, Inc. The Company has its main market of operations in Kazakhstan and has operations through its subsidiaries in 22 countries. To learn more about Freedom Holding Corp., visit Cautionary Note Regarding Forward-Looking Statements This release contains "forward-looking" statements within the meaning of section 21E of the Securities Exchange Act of 1934. All forward-looking statements are subject to uncertainty and changes in circumstances. In some cases, forward-looking statements can be identified by terminology such as "expect," "new," "plan," "seek," and "will," or the negative of such terms or other comparable terminology and include statements relating to our plans, intentions and expectations including our plans to enter the telecommunications market, our expectations with respect to further years and other non-historical statements. Forward-looking statements are not guarantees of future results or performance and involve risks, assumptions, and uncertainties that could cause actual events or results to differ materially from the events or results described in, or anticipated by, the forward-looking statements. Factors that could materially affect such forward-looking statements include economic, business, and regulatory risks and other factors including those identified in the Company's periodic and current reports filed with the U.S. Securities and Exchange Commission. All forward-looking statements are made only as of the date of this release and the Company assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Website Disclosure Freedom Holding Corp. intends to use its website, as a means for disclosing material non-public information and for complying with U.S. Securities and Exchange Commission Regulation FD and other disclosure obligation. FREEDOM HOLDING CORP. (All amounts in thousands of United States dollars, unless otherwise stated) Three Months Ended June 30, 2025 2024 Revenue: Fee and commission income $ 107,642 $ 115,489 Net gain/(loss) on trading securities 45,602 (52,102 ) Interest income 198,571 226,004 Insurance premiums earned, net of reinsurance 153,257 129,408 Net (loss)/ gain on foreign exchange operations (12,893 ) 8,089 Net gain on derivatives 15,459 12,494 Sales of goods and services 17,224 5,220 Other income 8,561 10,397 TOTAL REVENUE, NET $ 533,423 $ 454,999 Expense: Fee and commission expense $ 84,871 $ 80,147 Interest expense 113,410 145,718 Insurance claims incurred, net of reinsurance 80,285 47,309 Payroll and bonuses 93,101 57,524 Professional services 13,024 7,268 Stock compensation expense 23,054 10,615 Advertising and sponsorship expense (including for the three months ended $5,513 and $2,045 from related parties) 24,463 21,896 General and administrative expense 41,975 40,410 Allowance for/(recovery of) expected credit losses 4,822 (1,770 ) Cost of sales 13,903 4,284 TOTAL EXPENSE $ 492,908 $ 413,401 INCOME BEFORE INCOME TAX 40,515 41,598 Income tax expense (10,119 ) (7,339 ) NET INCOME $ 30,396 $ 34,259 Less: Net loss attributable to non-controlling interest in subsidiary — (141 ) NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 30,396 $ 34,400 OTHER COMPREHENSIVE INCOME Change in unrealized gain on investments available-for-sale, net of tax effect 2,998 3,374 Reclassification adjustment for net realized loss/(gain) on available-for-sale investments disposed of in the period, net of tax effect 174 (18 ) Foreign currency translation adjustments (41,804 ) (65,811 ) OTHER COMPREHENSIVE LOSS (38,632 ) (62,455 ) $ (8,236 ) $ (28,196 ) — (141 ) $ (8,236 ) $ (28,055 ) EARNINGS PER COMMON SHARE (In U.S. dollars): Earnings per common share - basic 0.51 0.58 Earnings per common share - diluted 0.50 0.57 Weighted average number of shares (basic) 59,853,479 59,258,085 Weighted average number of shares (diluted) 61,057,627 60,255,593 Expand
Business Wire
2 hours ago
- Business Wire
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted an equity award in the form of stock options to purchase 11,000,000 shares of common stock to Harout Semerjian, Geron's new President and Chief Executive Officer, as an inducement material to his acceptance of employment with Geron. The stock options were granted on August 7, 2025. The stock options have an exercise price of $1.30 per share, which is equal to the closing price of Geron common stock on the grant date and have a ten-year term. 7,000,000 of the stock options vest over four years, with 12.5% of the shares underlying the options vesting on the six-month anniversary of commencement of his employment and the remaining shares vesting over the following 42 months in equal installments of whole shares, subject to continued employment with Geron through the applicable vesting dates. 4,000,000 of the stock options vest over four years, with 25% of the shares underlying the options vesting on the one-year anniversary of commencement of his employment and the remaining shares vesting over the following 36 months in equal installments of whole shares, subject to continued employment with Geron through the applicable vesting dates. The stock options were granted by Geron's Board of Directors (the 'Board'), upon recommendation of the Compensation Committee of the Board, in accordance with Nasdaq Listing Rule 5635(c)(4) and are subject to the terms and conditions of Geron's 2018 Inducement Award Plan and the form of stock option agreement under the plan. About Geron Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO® (imetelstat) is approved in the United States and the European Union for the treatment of certain adult patients with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis, as well as studies in other myeloid hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to reduce proliferation and induce death of malignant cells. To learn more, visit or follow us on LinkedIn.
Business Upturn
3 hours ago
- Business Upturn
KLEEN HY-DRO-GEN INC., Announces Launch of World's First Zero-Emissions Hydrogen Furnace
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) — KLEEN HY-DRO-GEN INC., has officially announced the launch of KLEENHEAT™ hydrogen furnace, the world's first and only on-demand, zero-emissions home heating system powered by water. The announcement comes ahead of the company's anticipated listing on the Canadian Securities Exchange (CSE) this September, marking a major milestone in its journey to bring sustainable, home-grown hydrogen solution to the global stage. Now in its third year of testing, KLEENHEAT™ has been operating in a model home designed to educate the public on hydrogen heating-a safer, cleaner, zero-emissions alternative to fossil fuels. The system generates hydrogen and oxygen from water using electrolysis, producing only water vapor as a byproduct. The system is designed for homeowners and manufacturers. With no gas storage, advanced safety features, and compatibility with existing HVAC and renewable systems, KLEENHEAT™ is efficient and secure. Users may also qualify for government rebates and carbon credits, contributing to long-term savings. Following a successful multi-year pilot trial in Ajax, Ontario, the company is preparing to expand into residential and commercial markets across Canada and beyond. Several units have already been tested, paving the way for broader rollout post-CSE listing. 'This is more than a launch, it's a vision for what the global heating industry will look like in the near future', says Thomas Fairfull, President, and CEO. 'We've developed a solution that doesn't just reduce emissions but eliminates them safely. Our focus is on sharing this innovation with the world and building partnerships that will bring KLEENHEAT™ into homes across the country.' Fairfull brings over 25 years of leadership in Canada's energy and tech sectors, previously named one of Ontario Business Report's Top 100 Entrepreneurs and an Ernst & Young Entrepreneur of the Year finalist. Under his leadership, the company is scaling its impact and building partnerships to expand globally. For media inquiries or demo requests, please contact, Arthur Crapopoulos, VP of Marketing at [email protected]. About KLEEN HY-DRO-GEN INC. KLEEN HY-DRO-GEN INC. is a Canadian clean energy company dedicated to developing zero-emission hydrogen technology for residential and commercial heating. With a focus on innovation, sustainability, and safety, the company aims to lead the shift toward a net-zero future through the KLEENHEAT™ system. Learn more at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
